Patients with gastric cancer may be at higher risk of cardiovascular death
1. In this cohort of patients with gastric cancer, there was a significantly higher risk of cardiovascular death compared with...
1. In this cohort of patients with gastric cancer, there was a significantly higher risk of cardiovascular death compared with...
1. In non-valvular atrial fibrillation (NVAF) patients taking direct oral anticoagulants (DOACs), adding amiodarone, diltiazem, dronedarone, or verapamil does not...
1. Ticagrelor led to a smaller 30-day cardiac magnetic resonance (CMR)-defined infarct size than clopidogrel in pharmaco-invasive STEMI Evidence Rating...
1. All-cause mortality and reduction in major amputations were similar between groups. 2. The rate of target vessel reintervention was...
1. Intensive systolic blood pressure (SBP) management reduces hypertension-mediated retinal microvascular damage in populations with high cardiovascular risk Evidence Rating...
1. Major adverse cardiovascular and cerebrovascular events were significantly reduced with clopidogrel compared to aspirin alone. 2. There was no...
1. All-cause mortality and hospital readmissions were significantly decreased with influenza vaccination compared to usual care. 2. Significantly fewer adverse...
1. In this prospective cohort study, cumulative all-cause mortality and risk for cardiovascular disease were lower among adults who accumulated...
1. At one month, ticagrelor was not superior to twice-daily clopidogrel in reducing major adverse cardiovascular events (MACEs) in adult...
1. In this randomized controlled trial, a multidomain rehabilitation program significantly reduced cardiovascular death and unplanned cardiac hospitalizations in older...
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free · only $4.16/month
Then $49.90/year. Manage renewal in your account.
Already a member? Sign in